# 902 KAR 55:015: 902 KAR 55:015. Schedules of controlled substances > Kentucky · Regulations · In force URL: https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R015 ## Section - **Citation:** 902 KAR 55:015 - **Heading:** 902 KAR 55:015. Schedules of controlled substances - **Jurisdiction:** Kentucky - **Kind:** Regulations - **Status:** In force - **Text as of:** August 14, 2026 - **Source:** Compiled text - **Location:** Kentucky Administrative Regulations / Title 902 (Cabinet for Health and Family Services - Department for Public Health) / Chapter 055 / 902 KAR 55:015 ## Text Section 1. Schedule I Controlled Substances. (1) Each substance that is scheduled or designated as a Schedule I controlled substance under 21 C.F.R. 1308.11, including a substance temporarily scheduled or designated under 21 C.F.R. 1308.11(h) or 1308.49, shall be scheduled or designated at the state level as a Schedule I controlled substance. (2) The Cabinet for Health and Family Services designates the following as Schedule I controlled substances: (a) tianeptine; (b) bromazolam; and (c) 7-hydroxymitragynine (7-OH) concentrated at a level above 400 parts per million on a dry weight basis. This designation does not apply to mitragynine. (3) The following shall be exempt from control as a Schedule I substance: (a) Cannabis plant material, and products made therefrom, that contain tetrahydrocannabinols pursuant to the exemption established in 21 C.F.R. 1308.35; and (b) Any substance or product exempt from the definition of marijuana pursuant to KRS 218A.010(27)(a) – (f). Section 2. Schedule II Controlled Substances. Each substance that is scheduled or designated as a Schedule II controlled substance under 21 C.F.R. 1308.12 shall be scheduled or designated at the state level as a Schedule II controlled substance. Section 3. Schedule III Controlled Substances. (1) Except as provided by subsection (2) of this section, each substance that is scheduled or designated as a Schedule III controlled substance under 21 C.F.R. 1308.13 shall be scheduled or designated at the state level as a Schedule III controlled substance. (2) The Cabinet for Health and Family Services designates the following as Schedule III controlled substances: (a) Pentazocine; (b) Barbital; (c) Methylphenobarbital; and (d) Phenobarbital section, each substance that is scheduled or designated as a Schedule III controlled substance under 21 C.F.R. 1308.13 shall be scheduled or designated at the state level as a Schedule III controlled substance. (2) The Cabinet for Health and Family Services designates the following as Schedule III controlled substances: (a) Pentazocine; (b) Barbital; (c) Methylphenobarbital; and (d) Phenobarbital. (3) This section shall not apply to any material, compound, mixture, or preparation containing any quantity of an anabolic steroid substance, or any isomer, ester, salt, or derivative thereof that is: (a) Expressly intended for administration through implant to livestock or other nonhuman species; and (b) Approved by the United States Food and Drug Administration for use as described in this subsection. Section 4. Schedule IV Controlled Substances. (1) Except as provided by subsection (2) of this section and Section 3(2) of this administrative regulation, each substance that is scheduled or designated as a Schedule IV controlled substance under 21 C.F.R. 1308.14 shall be scheduled or designated at the state level as a Schedule IV controlled substance. (2) The Cabinet for Health and Family Services designates the following as a Schedule IV controlled substance: nalbuphine. Section 5. Schedule V Controlled Substances. (1) Except as provided by subsection (2) of this section, each substance that is scheduled or designated as a Schedule V controlled substance under 21 C.F.R. 1308.15 shall be scheduled or designated at the state level as a Schedule V controlled substance. (2) The Cabinet for Health and Family Services designates the following as a Schedule V controlled substance: gabapentin. Section 6. Dispensing Without Prescription. A controlled substance listed in Schedule V, which is not a prescription drug under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C . 1308.15 shall be scheduled or designated at the state level as a Schedule V controlled substance. (2) The Cabinet for Health and Family Services designates the following as a Schedule V controlled substance: gabapentin. Section 6. Dispensing Without Prescription. A controlled substance listed in Schedule V, which is not a prescription drug under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301 to 399f, may be dispensed by a pharmacist without a prescription to a purchaser at retail, if: (1) The medicinal preparation contains, in addition to the controlled substances, some drug or drugs conferring upon it medicinal qualities other than those possessed by the controlled substances alone; (2) Not more than 240cc (eight (8) ounces) or more than forty-eight (48) dosage units of any controlled substance containing opium is dispensed at retail to the same purchaser in any given forty-eight (48) hour period; (3) The labeling and packaging is in accordance with the current requirements of KRS 217.005 to 217.215, 21 U.S.C. 301 to 399f, and the United States Pharmacopeia; (4) The preparation is dispensed or sold in good faith as a medicine and not for the purpose of evading the provisions of KRS Chapter 218A; (5) The preparation is not displayed in areas open to the public; (6) The dispensing is made only by a pharmacist and not by a nonpharmacist employee even if under the supervision of a pharmacist. After the pharmacist has fulfilled his or her professional and legal responsibilities as set forth in this section, the actual cash, credit transaction, or delivery may be completed by a nonpharmacist; (7) The purchaser is at least eighteen (18) years of age; (8) The pharmacist requires every purchaser of a controlled substance under this section not known to the pharmacist to furnish suitable identification, including proof of age if appropriate; and (9) The dispensing of exempt controlled substances under this administrative regulation is recorded in a bound book that shall be maintained in accordance with the reco t least eighteen (18) years of age; (8) The pharmacist requires every purchaser of a controlled substance under this section not known to the pharmacist to furnish suitable identification, including proof of age if appropriate; and (9) The dispensing of exempt controlled substances under this administrative regulation is recorded in a bound book that shall be maintained in accordance with the recordkeeping requirements of KRS 218A.200 and contain the: (a) Name and address of the purchaser; (b) Name and quantity of controlled substance purchased; (c) Date of each purchase; and (d) Name or initials of the pharmacist who dispensed the substance to the purchaser. ## Nearby sections - [902 KAR 55:015 902 KAR 55:015. Schedules of controlled substances](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R015.md) - [902 KAR 55:040 902 KAR 55:040. Excluded nonnarcotic substances](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R040.md) - [902 KAR 55:060 902 KAR 55:060. Requirements for distribution of small amounts of controlled substances without manufacturer's or wholesaler's licenses](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R060.md) - [902 KAR 55:065 902 KAR 55:065. Return of prescription drugs prohibited, exceptions](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R065.md) - [902 KAR 55:070 902 KAR 55:070. Emergency medication kits in long-term care facilities](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R070.md) - [902 KAR 55:080 902 KAR 55:080. Written prescriptions to be signed by practitioner](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R080.md) - [902 KAR 55:090 902 KAR 55:090. Exempt anabolic steroid products](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R090.md) - [902 KAR 55:095 902 KAR 55:095. Prescription for Schedule II controlled substance – authorization of oral prescriptions for immediate administration, facsimile transmission, or partial filling](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R095.md) - [902 KAR 55:105 902 KAR 55:105. Controlled substance prescription blanks](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R105.md) - [902 KAR 55:110 902 KAR 55:110. Monitoring system for prescription controlled substances](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R110.md) - [902 KAR 55:115 902 KAR 55:115. Drug possession by hospice or home health agency](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R115.md) - [902 KAR 55:120 902 KAR 55:120. Disposal of prescription controlled substances](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R120.md) - [902 KAR 55:130 902 KAR 55:130. Electronic prescribing of controlled substances](https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R130.md) --- Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/STATE_KY_KAR_T902_C055_R015. Check the current official text before relying on it. Not legal advice.